{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:33:22Z","timestamp":1774611202567,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/tri.12832","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T15:56:46Z","timestamp":1471363006000},"page":"1276-1285","source":"Crossref","is-referenced-by-count":41,"title":["Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab"],"prefix":"10.3389","volume":"29","author":[{"given":"Joseph","family":"Kahwaji","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiad","family":"Najjar","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patarapha","family":"Wongsaroj","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jua","family":"Choi","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Villicana","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Vo","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center; Comprehensive Transplant Center; Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"10.1111\/tri.12832-BIB0001|tri12832-cit-0001","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12832-BIB0002|tri12832-cit-0002","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0003|tri12832-cit-0003","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12832-BIB0004|tri12832-cit-0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-6143.2007.02017.x","article-title":"Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab","volume":"8","author":"Vo","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0005|tri12832-cit-0005","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0006|tri12832-cit-0006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0007|tri12832-cit-0007","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000000525","article-title":"Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0008|tri12832-cit-0008","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0009|tri12832-cit-0009","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12832-BIB0010|tri12832-cit-0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive cross-match living donor kidney transplantation: longer-term outcomes","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0011|tri12832-cit-0011","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0012|tri12832-cit-0012","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007890-199502000-00006","article-title":"Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients","volume":"59","author":"De Geest","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0013|tri12832-cit-0013","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12832-BIB0014|tri12832-cit-0014","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ndt\/gfw027","article-title":"Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection","volume":"31","author":"Schwaiger","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12832-BIB0015|tri12832-cit-0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/TP.0b013e31821eab8a","article-title":"Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy","volume":"92","author":"Lai","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0016|tri12832-cit-0016","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.ajkd.2009.06.031","article-title":"Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management","volume":"54","author":"Knoll","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12832-BIB0017|tri12832-cit-0017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-6143.2007.02104.x","article-title":"Transplant glomerulopathy","volume":"8","author":"Cosio","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0018|tri12832-cit-0018","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e3181efcffd","article-title":"Determinants of long-term graft outcome in transplant glomerulopathy","volume":"90","author":"John","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12832-BIB0019|tri12832-cit-0019","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1432-2277.2012.01544.x","article-title":"IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up","volume":"25","author":"Billing","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12832-BIB0020|tri12832-cit-0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.transproceed.2011.12.006","article-title":"Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection","volume":"44","author":"Hong","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12832-BIB0021|tri12832-cit-0021","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ctr.12345","article-title":"Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab","volume":"28","author":"Kahwaji","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12832-BIB0022|tri12832-cit-0022","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0023|tri12832-cit-0023","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ackd.2012.05.006","article-title":"Controversies in kidney paired donation","volume":"19","author":"Gentry","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/tri.12832-BIB0024|tri12832-cit-0024","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1600-6143.2005.01048.x","article-title":"Characterization of waiting times in a simulation of kidney paired donation","volume":"5","author":"Segev","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12832-BIB0025|tri12832-cit-0025","unstructured":"National Kidney Registry Quarterly Report http:\/\/www.kidneyregistry.org\/pages\/p343\/NKRQuarterlyReport2ndQuarter.php 2015"},{"key":"10.1111\/tri.12832-BIB0026|tri12832-cit-0026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.transproceed.2012.08.007","article-title":"Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases","volume":"45","author":"Yabu","year":"2013","journal-title":"Transplant Proc"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12832","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12832","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12832\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:34:41Z","timestamp":1749062081000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12832","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}